(Q43825997)

English

Chemoprevention of breast cancer with selective estrogen receptor modulators: views from broadly diverse focus groups of women with elevated risk for breast cancer

scientific article published in November 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Chemoprevention of breast cancer with selective estrogen receptor modulators: views from broadly diverse focus groups of women with elevated risk for breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

author name string

Cyrus-David MS

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Strom SS

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 November 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Psycho-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

521-533

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Differences between African American and Caucasian men participating in a community-based prostate cancer screening program

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

The Tuskegee Syphilis Study

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Coming to terms with advanced breast cancer: black women's narratives from eastern North Carolina

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Compliance with mammography guidelines: physician recommendation and patient adherence

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Chemoprevention of breast cancer in the older patient

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Potential role of tamoxifen in prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Cancer and poverty: breaking the cycle

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Reverse Targeting of Preventive Care due to Lack of Health Insurance

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Final report on the "Tuskegee syphilis study".

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

The use of mammography by survivors of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Recent trends in U.S. breast cancer incidence, survival, and mortality rates

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Phase III, large-scale chemoprevention trials. Approach to chemoprevention clinical trials and phase III clinical trial of tamoxifen as a chemopreventive for breast cancer--the US National Cancer Institute experience

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Recent incidence trends for breast cancer in women and the relevance of early detection: an update

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Involving family members in cancer care: focus group considerations of patients and oncological providers

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Preclinical drug development paradigms for chemopreventives

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Use of focus groups with rural women of lower socioeconomic status

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Raloxifene, retinoids, and lavender: "me too" tamoxifen alternatives under study

1 reference

https://api.crossref.org/works/10.1002%2FPON.547

21 January 2018

Identifiers

10.1002/PON.547

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43825997&oldid=2103687415"